Related Experiment Video
Updated: May 3, 2026
07:48
Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis
Published on: January 7, 2019
6.2K
Radiolabeled NGR phage display peptide sequence for tumor targeting.
B L Faintuch1, E A Oliveira1, R C Targino2
1Radiopharmacy, Institute of Energy and Nuclear Research, Av. Prof. Lineu Prestes 2242, 05508-000 São Paulo, SP, Brazil.
Summary
The asparagine-glycine-arginine (NGR) peptide, radiolabeled with technetium-99m, shows potential for lung cancer imaging. While uptake was similar in ovarian and lung tumors, imaging studies favored lung tumor visualization.
Area of Science:
- Biomedical imaging
- Molecular imaging
- Radiopharmaceutical development
Background:
- The asparagine-glycine-arginine (NGR) peptide sequence was identified via phage display.
- Targeted delivery of diagnostic agents to tumors is crucial for effective cancer detection.
- Radiolabeling peptides allows for in vivo imaging and biodistribution studies.
Purpose of the Study:
- To evaluate the diagnostic potential of technetium-99m labeled NGR peptide in preclinical tumor models.
- To compare the uptake and imaging characteristics of the NGR peptide in ovarian and lung tumors.
- To assess the biodistribution and excretion profile of the radiotracer.
Main Methods:
- Phage display was used to identify the NGR peptide sequence.
- The NGR peptide was radiolabeled with technetium-99m (99mTc).
- In vivo biodistribution and imaging studies were performed in tumor-bearing animal models.
Main Results:
- Similar uptake of 99mTc-NGR was observed in both ovarian and lung tumor cells.
- Biodistribution studies showed predominant renal excretion.
- Ovarian tumor-bearing animals exhibited more substantial uptake, but imaging studies indicated better visualization of lung tumors.
- The NGR peptide demonstrated diagnostic potential, particularly for lung cancer.
Conclusions:
- Technetium-99m labeled NGR peptide is a promising diagnostic candidate, especially for lung cancer detection.
- Further improvements may be achieved by combining NGR with RGD peptides to form a heterodimer molecule.
- The study highlights the potential of targeted peptide imaging agents in oncology.
